CNTO 530 Increases Expression of HbA and HbF in Murine Models of β-Thalassemia and Sickle Cell Anemia

CNTO 530 is an erythropoietin receptor agonist MIMETIBODY(TM) construct. CNTO 530 has been shown to be active in a number of rodent models of acquired anemia (e.g. renal insufficiency and chemotherapy induced anemia). We investigated the efficacy of CNTO 530 in murine models of β-thalassemia and sic...

Descripción completa

Detalles Bibliográficos
Autores principales: Makropoulos, Dorie A, Achuthanandam, Ram, Avery, Justin, Wilson, Krista, Brosnan, Kerry, Miller, Andrew, Nesspor, Thomas, Chroscinski, Denise, Walker, Mindi, Egenolf, Devon, Huang, ChiChi, Bugelski, Peter J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613800/
https://www.ncbi.nlm.nih.gov/pubmed/23157711
http://dx.doi.org/10.2174/138920113805219449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613800/
https://www.ncbi.nlm.nih.gov/pubmed/23157711
http://dx.doi.org/10.2174/138920113805219449

Ejemplares similares